Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer

Summary

A clinical study of an immunotherapy in patients with head or neck cancers associated with the HPV16 virus

Timeline

Start

2024-08-23

Primary completion

2027-11

Completion

2029-11

Drugs

Indications